Abstract:AMPK phosphorylates epigenetic factors to couple mitochondrial biogenesis and function with cellular energy needs. Epigenetic control of mitochondria When cellular energy is low, cells activate the kinase AMPK, which promotes mitochondrial biogenesis and function. Marin et al. found that AMPK phosphorylated three proteins involved in nucleosome remodeling: the DNA methyltransferase DNMT1, the histone acetyltransferase HAT1, and RBBP7, which inhibits DNMT1 and is a HAT1 coactivator. AMPK-mediated phosphorylation of these proteins triggered nucleosome remodeling that favored the transcription of nuclear-encoded genes involved in mitochondrial biogenesis and function in human cultured endothelial cells and mouse aortas. These results show that AMPK coordinates mitochondrial function with energy status through epigenetic regulation of nuclear gene expression. Adenosine monophosphate (AMP)–activated protein kinase (AMPK) acts as a master regulator of cellular energy homeostasis by directly phosphorylating metabolic enzymes and nutrient transporters and by indirectly promoting the transactivation of nuclear genes involved in mitochondrial biogenesis and function. We explored the mechanism of AMPK-mediated induction of gene expression. We identified AMPK consensus phosphorylation sequences in three proteins involved in nucleosome remodeling: DNA methyltransferase 1 (DNMT1), retinoblastoma binding protein 7 (RBBP7), and histone acetyltransferase 1 (HAT1). DNMT1 mediates DNA methylation that limits transcription factor access to promoters and is inhibited by RBBP7. Acetylation of histones by HAT1 creates a more relaxed chromatin-DNA structure that favors transcription. AMPK-mediated phosphorylation resulted in the activation of HAT1 and inhibition of DNMT1. For DNMT1, this inhibition was both a direct effect of phosphorylation and the result of increased interaction with RBBP7. In human umbilical vein cells, pharmacological AMPK activation or pulsatile shear stress triggered nucleosome remodeling and decreased cytosine methylation, leading to increased expression of nuclear genes encoding factors involved in mitochondrial biogenesis and function, such as peroxisome proliferator–activated receptor gamma coactivator–1α (PGC-1α), transcription factor A (Tfam), and uncoupling proteins 2 and 3 (UCP2 and UCP3). Similar effects were seen in the aortas of mice given pharmacological AMPK activators, and these effects required AMPK2α. These results enhance our understanding of AMPK-mediated mitochondrial gene expression through nucleosome remodeling.

AMPK Promotes Osteogenesis and Inhibits Adipogenesis Through AMPK-Gfi1-OPN Axis.

Functional Differences Between AMPK Α1 and Α2 Subunits in Osteogenesis, Osteoblast-Associated Induction of Osteoclastogenesis, and Adipogenesis.

Exchange protein activated by cyclic adenosine monophosphate regulates the switch between adipogenesis and osteogenesis of human mesenchymal stem cells through increasing the activation of phosphatidylinositol 3-kinase.

The regulatory role of AMPK signaling pathway in bone metabolism

Suppression of AMP-activated protein kinase reverses osteoprotegerin-induced inhibition of osteoclast differentiation by reducing autophagy (vol 53, e12714, 2018)

AMP-activated Protein Kinase Stimulates Osteoblast Differentiation and Mineralization Through Autophagy Induction

Suppression of AMP‐activated protein kinase reverses osteoprotegerin‐induced inhibition of osteoclast differentiation by reducing autophagy

Adiponectin Stimulates Human Osteoblasts Proliferation and Differentiation Via the Mapk Signaling Pathway

AMPK Downregulates ALK2 Via Increasing the Interaction Between Smurf1 and Smad6, Leading to Inhibition of Osteogenic Differentiation

Constitutively activated AMPKα1 protects against skeletal aging in mice by promoting bone‐derived IGF‐1 secretion

Muscle-selective knockout of AMPKα2 does not exacerbate diet-induced obesity probably related to altered myokines expression.

AMP‐activated protein kinase (AMPK) regulates autophagy, inflammation and immunity and contributes to osteoclast differentiation and functionabs

Regulation Of Bmi-1 Expression By Ampk And Its Effect On The Proliferation Of Osteosarcoma Cells

AMPK, a hub for the microenvironmental regulation of bone homeostasis and diseases

Gene Expression Profiles and Phosphorylation Patterns of Amp-Activated Protein Kinase Subunits in Various Mesenchymal Cell Types

Adiponectin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells Through the Ampk/Mtor Pathway

ATP-binding Cassette G1 Regulates Osteogenesis Via Wnt/β-catenin and AMPK Signaling Pathways

Metformin activates AMPK and mTOR to Inhibit RANKL-stimulated osteoclast formation

AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1

Uncarboxylated osteocalcin promotes osteogenesis and inhibits adipogenesis of mouse bone marrow-derived mesenchymal stem cells via the PKA-AMPK-SIRT1 axis

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways